On or around 03/09/2017 (Other)
Filing Date: January 15, 2016
According to the law firm press release, the lawsuit alleges throughout the Class Period Defendants issued false and misleading statements to investors and/or failed to disclose that: (1) contrary to Defendants’ assurances, the mandated pulmonary testing or spirometry was still a significant issue impeding sales of Afrezza; and (2) as a result, Defendants’ statements about MannKind’s business, operations, and prospects, were false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.
On May 12, 2016, the Court issued an Order appointing lead plaintiffs. On May 17, the Court also approved lead counsel. Lead Plaintiffs filed an amended complaint on June 15.
On August 23, 2016, the Court issued an Order granting Defendants' motion to dismiss without leave to amend. Plaintiffs filed a Notice of Appeal of this Order on October 11. Plaintiffs voluntarily dismissed their Appeal on March 9, 2017.
Company & Securities Information
Defendant: MannKind Corporation
Industry: Biotechnology & Drugs
Headquarters: United States
Ticker Symbol: MNKD
Company Market: NASDAQ
Market Status: Public (Listed)
About the Company & Securities Data
"Company" information provides the industry and sector classification and headquarters state for the primary company-defendant in the litigation. In general, "Securities" information provides the ticker symbol, market, and market status for the underlying securities at issue in the litigation.
In most cases, the primary company-defendant actually issued the securities that are the subject of the litigation, and the securities information and company information relate to the same entity. In a small subset of cases, however, the primary company-defendant is not the issuer (for example, cases against third party brokers/dealers), and the securities information and company information do not relate to the same entity.
First Identified Complaint
Eric Ardolino, et al. v. MannKind Corporation, et al.